Skip to content

PTSD: all studies

Page 38 of 210: studies 371 to 380 of 2,096, newest first. Back to the PTSD overview

Research

Interoception Underlies Therapeutic Effects of Mindfulness Meditation for Posttraumatic Stress Disorder: A Randomized Clinical Trial.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging August 1, 2022 Seung Suk Kang, Scott R Sponheim, Kelvin O Lim

Mindfulness-based interventions have proven efficacy in treating posttraumatic stress disorder (PTSD), but the neurobiological mechanism underlying the therapeutic effects is unknown. As mindfulness meditation cultivates attention to the present moment and bodily sensations, neural functions related to interoception (i.e., central processes of bodily signals) might be such a mechanism. We...

Visual phenomenology in schizophrenia and post-traumatic stress disorder: an exploratory study.

BJPsych Open July 25, 2022 Deborah Wearne, Jeremiah Ayalde, Guy Curtis et al. 10 citations

Visual experiences such as hallucinations are commonly reported by people with psychosis, psychological trauma and dissociative states, although questions remain about their similarities and differences. For diagnostic and therapeutic purposes, clinical research must better delineate and compare the characteristics of these experiences in post-traumatic stress disorder (PTSD) and in...

DOI: 10.1192/bjo.2022.544 (opens in new tab) Full text (opens in new tab) PTSD Visual hallucinations Dissociation Schizophrenia +1

Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study

Psychiatry Research Case Reports July 15, 2022 Mika Turkia 14 citations

This article describes a case of a teenager with early complex trauma due to chronic domestic violence. Cannabis use triggered auditory hallucinations, after which the teenager was diagnosed with an acute schizophrenia-like psychotic disorder. Antipsychotic medication did not fully resolve symptoms. Eventually the teenager chose to self-medicate with LSD in order to resolve a suicidal...

DOI: 10.1016/j.psycr.2022.100029 (opens in new tab) Cannabis Psychosis Antipsychotic Schizophrenia object-oriented programming +2

Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study

Frontiers in Psychiatry July 8, 2022 Maud Rothärmel, Cherifa Benosman, Wissam El-Hage et al. 31 citations

Introduction: Major depressive disorder (MDD) is more likely to resist to usual treatment when it is associated with post-traumatic stress disorder (PTSD). Capitalizing on the effect of ketamine in both treatment-resistant depression (TRD) and PTSD, we conducted a study in order to assess the efficacy of intranasal (IN) Esketamine in patients having TRD with comorbid PTSD. Materials and...

Decreased Posttraumatic Stress Disorder Symptoms Following Lucid Dream Healing Workshop

PsyArXiv July 7, 2022 Garret Yount preprint

Objective: Recent investigations of lucid dreams – dreams with a veridical awareness of dreaming - suggest that this unique form of dreaming may be useful for promoting healing due to the lucid dreamer’s capacity for goal-directed action in the dream. Methods: Following a prospective, within-participant research design, 49 adults experiencing chronic post-traumatic stress disorder (PTSD)...

Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.

Neuropsychopharmacology July 2022 Chadi G. Abdallah, John D Roache, Ralitza Gueorguieva et al.

This study tested the efficacy of repeated intravenous ketamine doses to reduce symptoms of posttraumatic stress disorder (PTSD). Veterans and service members with PTSD (n = 158) who failed previous antidepressant treatment were randomized to 8 infusions administered twice weekly of intravenous placebo (n = 54), low dose (0.2 mg/kg; n = 53) or standard dose (0.5 mg/kg; n = 51) ketamine....

Characteristics of Sleep Paralysis and Its Association with Anxiety Symptoms, Perceived Stress, PTSD, and Other Variables Related to Lifestyle in Selected High Stress Exposed Professions.

International Journal of Environmental Research and Public Health June 25, 2022 Paulina Wróbel-knybel, Michał Flis, Joanna Róg et al.

Sleep paralysis (SP) is a hypnagogic or hypnopompic state associated with the inability to move while conscious. Recurrent isolated sleep paralysis (RISP) is a type of REM parasomnia. Individuals experiencing anxiety disorders, PTSD, exposure to chronic stress, or shift work are at risk of developing this sleep disorder. This study aimed to assess: (1) the prevalence, frequency, and...

MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial

Journal of Psychopharmacology June 21, 2022 Terence H. W. Ching, Monnica T. Williams, Julie B. Wang et al. 29 citations

Background: Limited ethnoracial diversity in previous ±3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) trials for posttraumatic stress disorder (PTSD) has prompted questions concerning whether Black, Indigenous, and People of Color (BIPOC) also benefit from this treatment. Methods: Secondary analysis was conducted using a modified intent-to-treat sample pooled from two Phase 2...

Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review

European Psychiatry June 1, 2022 J. Sá Couto, B. Da Luz, J. Rodrigues et al.

IntroductionPosttraumatic stress disorder (PTSD) is a psychiatric condition which can be developed following traumatic experience. Treatment guidelines have long considered psychotherapy as a first line treatment. Despite that, PTSD remains an illness with high rates of comorbidity. Therefore, exploring novel therapies is of utmost importance.ObjectivesClarifying methylenedioxymethamphetamine...